{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:49:15Z","timestamp":1768891755717,"version":"3.49.0"},"reference-count":10,"publisher":"Baishideng Publishing Group Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Methodol"],"abstract":"<jats:p>Recurrent aphthous stomatitis (RAS) is a very frequent condition in developed countries whose basic symptom is a lesion referred to as an aphthous ulcer. High levels of interleukin (IL)-1 and IL-6 and low salivary levels of IL-10 are the basis of RAS pathogenesis. Sublingual supplements based on IL-10 can be very useful in reducing the phenomenon of aphthous recurrence in patients with RAS. An observational clinical experience with a group of 5 patients with RAS receiving a commercially available IL-10-based supplement was reported by the authors. The findings revealed a subsequent reduction in the incidence of mouth ulcers.<\/jats:p>","DOI":"10.5662\/wjm.v15.i3.99176","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:50:31Z","timestamp":1741222231000},"source":"Crossref","is-referenced-by-count":3,"title":["Interleukin 10 supplement to reduce episodes of recurrent aphthous stomatitis"],"prefix":"10.5662","volume":"15","author":[{"given":"Cinzia","family":"Casu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo Michele","family":"Inchingolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germano","family":"Orr\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2023.05.007"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/prd.12262"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.23804\/ejpd.2022.23.01.14"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2017.0072"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15500"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-019-03144-z"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8517470"},{"key":"B8","unstructured":"Roberti ML, Ricottini L, Capponi A, Sclauzero E, Vicenti P, Fiorentini E, Savoia C, Scornavacca G, Brazioli D, Gaio L, Giannetti R, Ignazzi C, Meloni G, Chinni LM. Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgaris. J Biol Regul Homeost Agents 2014; 133-139"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.12.008"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.08.033"}],"container-title":["World Journal of Methodology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2222-0682\/full\/v15\/i3\/99176.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2222-0682\/full\/v15\/i3\/99176.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:51:10Z","timestamp":1741222270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2222-0682\/full\/v15\/i3\/99176.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":10,"journal-issue":{"issue":"3"},"alternative-id":["99176"],"URL":"https:\/\/doi.org\/10.5662\/wjm.v15.i3.99176","relation":{},"ISSN":["2222-0682"],"issn-type":[{"value":"2222-0682","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,20]]}}}